Periodic Report - NEURINOX (NOX enzymes as mediators of inflammation-triggered neurodegeneration: modulating NOX enzymes as novel therapies)
Project ID: 278611Funded under: FP7-HEALTH
This is the first periodic report for the NEURINOX project. Funded under the European Commission (EC)'s Seventh Framework Programme (FP7), NEURINOX aims to elucidate the links between neuroinflammation, nitrogen oxide (NOX) enzyme activities and neurodegenerative diseases and to validate NOX enzymes as therapeutic targets using animal models of neuroinflammation, human samples, prospective clinical studies and an early clinical trial with Amyotrophic lateral sclerosis (ALS) patients. The report covers a summary description of the project context and objectives, including also the approaches adopted. It goes on with the work performed and the related results with regards to the different NEURINOX research areas and closes outlining the expected final results and potential impact and use. A list of the project consortium is also included.
Download application/zip (427967)
Record Number: 15475 / Last updated on: 2014-07-04